Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for home prothrombin time/international normalized ratio (PT/INR) monitoring for anticoagulation management, effective May 15, 2026. Here's what billing teams need to know before that date.
This CMS PT/INR monitoring coverage policy governs whether Medicare will pay for patients to self-test coagulation levels at home using portable monitoring devices. The policy does not list specific codes in the data provided to us — so we'll walk through what billing teams should expect based on how CMS has historically structured this coverage, what the modification signals, and exactly where your exposure sits. If you bill home PT/INR monitoring for anticoagulation management, this change belongs on your radar now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS |
| Policy | Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation Management |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Cardiology, hematology, primary care, anticoagulation clinics, DME suppliers |
| Key Action | Review documentation requirements and medical necessity criteria for all active home PT/INR monitoring claims before May 15, 2026 |
CMS Home PT/INR Monitoring Coverage Criteria and Medical Necessity Requirements 2026
Home PT/INR monitoring sits in a specific coverage lane under Medicare. CMS covers it for patients on long-term oral anticoagulation therapy — most commonly warfarin — who meet defined medical necessity criteria. The core question the policy answers is: when does CMS consider it medically necessary for a patient to self-test INR at home rather than visit a lab or clinic?
Historically, CMS has required that patients meet all of the following before home monitoring is covered: the patient must have a condition requiring chronic anticoagulation therapy, the patient or a caregiver must be capable of self-testing, and a physician must review the results and adjust therapy accordingly. This is not a self-managed program in isolation. Medicare expects physician oversight built into the workflow.
The modification effective May 15, 2026 signals a change to one or more of those elements — documentation requirements, coverage criteria, or the structure of medical necessity review. Because the published policy data does not detail the exact language changes, your safest move before May 15 is to pull the current policy text directly from the CMS source and compare it line by line against your existing documentation protocols.
The Centers for Medicare & Medicaid Services has historically tied this coverage policy tightly to a National Coverage Determination framework. That means Medicare Administrative Contractors generally follow the national standard, though some MACs have issued local coverage determinations that add criteria on top of the national floor. Check with your MAC if you're unsure whether an LCD applies in your region.
Prior authorization is not typically required under Medicare for home PT/INR monitoring the way it is under commercial plans — but prior authorization requirements can apply when a patient is enrolled in a Medicare Advantage plan rather than traditional fee-for-service. If your patient population includes Medicare Advantage, treat those as separate coverage policy reviews.
Coverage Indications at a Glance
The policy data provided does not include a detailed, indication-level breakdown. The table below reflects the general CMS coverage framework for home PT/INR monitoring based on established Medicare policy. Verify against the current policy text at app.payerpolicy.org/p/cms/269-v2. before billing after May 15, 2026.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Long-term oral anticoagulation therapy (e.g., warfarin) requiring chronic INR management | Covered when medical necessity criteria are met | Not listed in policy data | Physician oversight and patient/caregiver self-test capability required |
| Patient or caregiver capable of operating home monitoring device | Covered (prerequisite condition) | Not listed in policy data | Training documentation typically required |
| Short-term anticoagulation therapy not requiring chronic management | Not covered | Not listed in policy data | Temporary therapy does not meet medical necessity threshold |
| Self-testing without documented physician review of results | Not covered | Not listed in policy data | Physician review and therapy adjustment are coverage conditions |
| Medicare Advantage enrollees | Subject to plan-specific prior authorization | Not listed in policy data | Review each plan's coverage policy separately |
CMS Home PT/INR Monitoring Billing Guidelines and Action Items 2026
Home PT/INR monitoring billing has always required tight documentation. This modification raises the stakes. Here's what to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull the updated policy text now. Go to the CMS source directly. Read the modified language. Don't rely on summaries — including this one. The specific criteria change is what drives your claim denial risk. |
| 2 | Audit your active home PT/INR monitoring patients. For every patient you currently bill under this coverage, confirm their documentation meets whatever the updated medical necessity criteria require. If a patient's file was compliant before May 15 but doesn't address new criteria, those claims are exposed. |
| 3 | Update your ABN workflow. If a patient may no longer qualify under the modified criteria, issue an Advance Beneficiary Notice of Noncoverage before providing the service. This protects you from holding the financial liability. |
| 4 | Review your DME supplier relationships. Home PT/INR monitoring involves durable medical equipment — the portable coagulometer the patient uses at home. If your practice coordinates with a DME supplier, confirm they've updated their billing guidelines and documentation requirements to match the May 15, 2026 changes. A documentation gap on the DME side can create a claim denial on both sides. |
| 5 | Check your Medicare Advantage contracts separately. Traditional Medicare fee-for-service follows the CMS national policy. Medicare Advantage plans set their own prior authorization requirements and may or may not mirror CMS exactly. Review each plan's coverage policy for home INR monitoring before May 15. |
| 6 | Train your clinical staff on the documentation trigger. The most common reason home PT/INR monitoring claims get denied is incomplete documentation of physician oversight. Make sure whoever documents the therapy review and INR result interpretation knows exactly what the updated policy requires. |
| 7 | Loop in your compliance officer before the effective date. If your practice does significant volume in anticoagulation management, the revenue exposure from a documentation gap is real. Have your compliance officer or billing consultant review the updated policy language and sign off on your revised process before May 15, 2026. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Home PT/INR Monitoring Under This Policy
The policy data provided to us does not list specific CPT, HCPCS, or ICD-10 codes. We do not invent codes.
That said, home PT/INR monitoring billing has historically involved a specific set of codes that you should verify against the updated policy text. Do not update your charge capture based on assumed codes. Pull the current CMS policy from the source, confirm which codes the modified policy addresses, and then update your systems.
If you need help identifying the correct codes for this service category, talk to your billing consultant or check with your MAC. This is not the place to guess — a wrong HCPCS code on a home monitoring claim will get denied, and the correction process costs more time than getting it right the first time.
What to Look For in the Policy Text
When you pull the updated CMS policy, look specifically for:
- Any HCPCS codes associated with the home coagulometer device itself
- Any CPT codes associated with the PT/INR test interpretation
- ICD-10-CM diagnosis codes listed as covered indications — particularly codes for conditions requiring chronic anticoagulation such as atrial fibrillation, mechanical heart valve, or venous thromboembolism
- Any coding notes about who bills what — the physician, the DME supplier, or the clinical lab
The billing structure for home PT/INR monitoring spans multiple claim types. Device billing, test billing, and physician management billing can all flow separately. A modification to the coverage policy can affect any one of those streams — or all three.
Why This Modification Matters More Than It Looks
Here's the honest take: a "modified" designation on a CMS coverage policy for home PT/INR monitoring is not a minor housekeeping update. CMS modifies these policies when clinical evidence shifts, when claims data shows billing abuse patterns, or when the coverage criteria need tightening. Any of those three reasons creates real claim denial risk for practices that don't update their documentation before the effective date.
Anticoagulation management is a high-volume, chronic-disease billing area. Patients on long-term warfarin therapy often have years of continuous claims. If the modified coverage policy tightens the medical necessity definition or adds a new documentation requirement, every active patient in your system needs to be re-evaluated for compliance — not just new patients going forward.
The other issue worth naming: home PT/INR monitoring sits at the intersection of DME billing and professional billing. That means two separate claim streams, often billed by two separate entities, both subject to the same policy change. Coordination between your practice and any DME supplier you work with is not optional here.
Reimbursement for home monitoring services is tied directly to documentation quality. CMS auditors and RAC contractors have historically targeted home monitoring claims because the documentation requirements are specific and the deviation patterns are easy to spot. A modified policy is a signal that CMS is paying attention to this service category.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.